glp 1 compound news versions of GLP-1 drugs for weight loss halted by FDA @goodmorningamerica @abcnews , https://abcnews.go.com/wellness/story/compound-versions-weight-loss-drugs-longer-fda-rules/?id=119665010 Compounded" GLP-1 drugs | Health

Dual agonist (Tirzepatide): Mentioned earlier, tirzepatide (Lilly) is a single peptide that activates both the GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors

Those on around 300 mg had an 83 percent greater risk of dying, and those on 400 mg or more appeared to double their risk for death

The benefits of improved glycemic control and weight loss must be weighed against potential risks in the context of your complete medical history and risk factor profile

It is food inspiration, not medication-specific medical advice

Any source claiming to sell retatrutide in a Mexican pharmacy is selling either a counterfeit, a research chemical, or something else entirely